Top

Biomanufacturing Process Development

Active

SBIR / STTR

Response Deadline07/08/2026, 04:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

U.S. Department of Defense → Defense Advanced Research Projects AgencyView Agency

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

Not specified

Set-Aside

SBA

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJun 24

subcontract

Response DeadlineJul 8

Submission deadline

Response Deadline

07/08/2026, 04:00:00 PM UTCin 13 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyU.S. Department of Defense → Defense Advanced Research Projects Agency

ContactsNo contacts available

OfficeN/A

Organization / Agency

U.S. Department of Defense → Defense Advanced Research Projects Agency

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Develop scalable biomanufacturing processes using engineered microbes or enzymatic systems to produce hierarchical biocomposites with reproducibility and yield optimization.

Similar Contracts

NAICS: 325412

New

Federal

Azithromycin Tablets SolicitationThe solicitation for Azithromycin Tablets, identified by solicitation number SPE2D2-26-R-0008, is a firm-fixed-price requirements contract issued by the Defense Logistics Agency Troop Support under NAICS code 325412, aiming to procure multiple dosage forms of Azithromycin tablets—including 250 mg, 500 mg, and 600 mg strengths in various bottle counts—primarily for use by DoD, VA, BoP, and IHS medical facilities through Prime Vendor (PPV) contractors. The contract envisions a one-year base period with four option years, potentially extending the total performance period to five years, and requires the contractor to fulfill orders within 15 calendar days of receipt and be operational for fulfillment no later than 45 days after award, with FOB Destination terms applying. All products must meet stringent packaging criteria: glass bottles are prohibited, each unit must contain a childproof safety cap, and bottles must be cylindrical with a minimum 100cc volume and 5.75-inch circumference to accommodate standardized labeling. Bar code requirements are highly specific, mandating linear HIBC or GS1-128 compliance at the unit-of-use level, with expiration date and lot number encoded, proper quiet zones, ladder orientation on vials, and no printing across blister pack perforations, all while ensuring a minimum barcode quality grade of C per ANSI, ISO, or IEC standards. The contract also enforces strict compliance with the Trade Agreements Act, requiring full disclosure of the country of origin for both the finished product and its active pharmaceutical ingredients, with FDA approval via NDA, ANDA, or BLA mandatory for all offered drugs. The solicitation explicitly states that Amendment 3 removed line item 5 from the original schedule, requiring proposers to reference the updated schedule of supplies on page 5. Proposals must be submitted exclusively via the DIBBS platform by June 16, 2026, at 3:00 PM ET, and must be organized into two volumes: the first containing the signed SF 1449, full solicitation documentation, and a detailed Trade Agreements chart identifying country-of-origin for all end products and APIs; the second containing pricing data for line items 0001–0005. Offerors must be registered in SAM with current representations and certifications—including those related to defense telecommunications prohibitions, economic price adjustments,

POSTED

DEADLINE

6505--RFI - DRAFT SOW for PPV 2028 Amendment to Extend Response Date from July 2, 2026 to July 10, 2026 11:00AM CT.The Department of Veterans Affairs is conducting an industry engagement initiative to gather feedback on the draft Statement of Work for the Pharmaceutical Prime Vendor 2028 acquisition, with a revised response deadline of July 10, 2026, at 11:00 AM Central Time. This request is not a solicitation and does not obligate the government to issue a future contract or make an award; participation is voluntary and intended solely to refine requirements and improve the quality of the final SOW. Industry participants are invited to comment on clarity, technical feasibility, operational challenges, and alignment with best practices across distribution, inventory management, reporting, data exchange, and order fulfillment. Feedback must include the company name, point of contact details, UEI and CAGE codes, and socioeconomic designations if applicable, and should be submitted to Karen Ade at Karen.Ade@va.gov. The NAICS code associated with this effort is 325412, and the contract will be administered by the VA National Acquisition Center based in Hines, Illinois. The Pharmaceutical Prime Vendor 2028 contract will require the vendor to distribute all pharmaceutical products under Federal Supply Class 65 to VA medical centers, satellite facilities, CMOPs, and IHS locations, including overseas sites. Key obligations include maintaining electronic ordering and paperless invoicing systems, managing supplier back orders and stockouts, handling product recalls, and ensuring compliance with the Veterans Health Care Act of 1992 by adhering strictly to the Federal Ceiling Price for covered drugs. Pricing structures are defined across multiple line items for brand and generic pharmaceuticals, specialty products, and WAC-based generics, each with FastPay and Net 30 payment terms, and all prices must include a 0.25% Cost Recovery Fee. The vendor must comply with the Drug Supply Chain Security Act by providing full transaction data for covered transactions and deploying the D barcode standard, and must also meet Trade Agreements Act requirements by tracking and reporting non-TAA compliant products weekly. Packaging requirements mandate hazardous drugs be segregated in impervious plastic and clearly labeled as NIOSH Hazardous Drug, with all pallets bearing permanent, human-readable and 2D barcode labels containing critical information such as CMOP station number, PO number, invoice number, drug name, and quantity. A 120-day transition period follows award before formal performance begins, and the contract includes a base period with three one-year option periods. The vendor must maintain current state and federal licenses,

Nac Prime Vendor (36W797)

POSTED

DEADLINE

Electrolytes SupplyDeKalb County is seeking suppliers to provide electrolyte blocks for animal care purposes through a subcontract arrangement, with the solicitation posted on June 23, 2026, and responses due by July 23, 2026. The procurement falls under NAICS code 325412, which pertains to the manufacturing of other inorganic chemical products, indicating the electrolyte blocks are specialized industrial or veterinary-grade formulations. The contract is being managed by the Georgia agency's Purchasing & Contracting division, and all deliveries are intended to support animal care needs within DeKalb County, though specific performance locations are not detailed. There is no set-aside designation or specialized procurement category applied to this solicitation, making it open to qualified vendors without restriction. Interested parties must submit proposals via the provided online portal before the deadlines to be considered for award.

Purchasing & Contracting

POSTED

DEADLINE

ALBENDAZOLE TABLETSThe contract pertains to the procurement of ALBENDAZOLE TABLETS under the NSN 6505-01-649-3422 with a requested quantity of four units. The solicitation, identified by number SPE2DP-26-T-3891, was posted on June 23, 2026, and responses are due by June 29, 2026. This procurement is managed by the Defense Logistics Agency within the Department of Defense and is designated as a federal solicitation with no specific set-aside classification. The place of performance and office address details are not specified, but the contract is governed under U.S. federal procurement parameters. Interested parties can access further details through the provided DIBBS link for submission and compliance purposes.

Defense Logistics Agency

POSTED

DEADLINE

Notice of Intent to Sole Source SIRTEX MEDICAL, INCThe Defense Health Agency Contracting Activity intends to award a sole-source firm-fixed price delivery order contract to SIRTEX MEDICAL, INC., for SIR-Spheres (Yttrium-90 Micro Resin Spheres) and associated accessories to meet an urgent medical need at Madigan Army Medical Center in Washington. This action is justified under FAR 12.102(b) because SIRTEX is the only supplier capable of providing the specialized radiological treatment product within the required emergency timeline; delays would necessitate additional surgeries and result in serious adverse patient outcomes. The contract is for a single delivery scheduled for July 1, 2026, and the requirement falls under NAICS code 325412 with a business size standard of 1,300 employees. The product is classified under PSC 3650, and the vendor is uniquely identified by UEI CWH2GM13A2V6 and CAGE code 45EE6. This notice serves solely as an announcement of intent and is not a solicitation for competitive bids. Interested parties may submit a capability statement of no more than eight pages to demonstrate their ability to meet the urgent specifications, but such submissions are for evaluation purposes only and will not be treated as competing offers unless they convincingly prove alternative capability. All submissions must be sent via email as a Word or PDF document to the designated point of contact by 10:00 a.m. Pacific Time on July 2, 2026. No telephone inquiries or offers will be accepted. The government retains full discretion to proceed with the sole-source award based on market research, historical use, and the absence of any other viable source, and any challenge to the requirement must be filed by the specified deadline.

Defense Health Agency Hcd West

POSTED

2 days ago

DEADLINE

in 7 days

View Details